13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 24 holding rows worth $815,257,000.
- Accession
- 0001144204-17-027535
- Filer
- CIK 1346824
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 24 entries on the cover page, a total value of $815,257,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $815,257,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,088,651 | $194,938,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 5,409,990 | $151,480,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 1,625,211 | $123,565,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 13,633,220 | $57,396,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 2,184,047 | $36,190,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,489,795 | $29,314,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 1,351,808 | $28,780,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 2,348,422 | $27,570,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 2,451,237 | $26,596,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 704,701 | $24,883,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 298,935 | $12,579,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 828,283 | $10,478,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 489,828 | $10,286,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 532,426 | $9,073,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 1,820,138 | $9,010,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 1,025,291 | $8,818,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 240,000 | $8,786,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 725,000 | $8,374,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $8,257,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 700,000 | $8,155,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 636,248 | $8,150,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 591,070 | $4,616,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 354,200 | $4,056,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 79,899 | $3,907,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-17-027535 | this filing | 2017-05-15 | acceptance time not in the bulk data set |